Interferon Alfa in Treating Patients With Advanced Kidney Cancer

Completed · Phase 1/Phase 2

Conditions studied: Kidney Cancer

In brief

RATIONALE: Interferon alfa may interfere with the growth of cancer cells. PURPOSE: Phase I/II trial to study the effectiveness of interferon alfa in treating patients with advanced kidney cancer.

Key facts

Study ID

NCT00003542

Run by

Memorial Sloan Kettering Cancer Center

People needed

58

Starts

1998-05-01

Expected to finish

2004-04-01

Last updated by the study team

2013-06-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Jonsson Comprehensive Cancer Center, UCLA — Los Angeles, California, United States
• Memorial Sloan-Kettering Cancer Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.